Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation—A SWEDEHEART study

AIMS: To describe the prevalence of atrial fibrillation (AF), use of oral anticoagulants (OAC) and change in antithrombotic treatment patterns during follow-up after valve intervention with a biological prosthesis or valvuloplasty. METHODS AND RESULTS: All patients with history of AF or new-onset AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Christersson, Christina, Held, Claes, Modica, Angelo, Westerbergh, Johan, Batra, Gorav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757947/
https://www.ncbi.nlm.nih.gov/pubmed/35025950
http://dx.doi.org/10.1371/journal.pone.0262580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757947/
https://www.ncbi.nlm.nih.gov/pubmed/35025950
http://dx.doi.org/10.1371/journal.pone.0262580

Ejemplares similares